MANUAL JET VENTILATOR (WITH REGULATOR AND GAUGE), MANUAL JET VENTILATOR (WITHOUT REGULATOR AND GAUGE), MODELS BE 183-SUR
Device Facts
| Record ID | K991785 |
|---|---|
| Device Name | MANUAL JET VENTILATOR (WITH REGULATOR AND GAUGE), MANUAL JET VENTILATOR (WITHOUT REGULATOR AND GAUGE), MODELS BE 183-SUR |
| Applicant | Instrumentation Industries, Inc. |
| Product Code | BTL · Anesthesiology |
| Decision Date | Aug 17, 1999 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 868.5925 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The BE 183-SUR and BE 183-SU Manual Jet Ventilators are designed to provide transtracheal ventilation in specific emergency situations of upper airway obstructions. These systems are used in conjunction with a transtracheal catheter, or cricothyrotomy needle, which is inserted through the cricothyroid membrane. Ventilation is accomplished by the manual, intermittent jetting of oxygen through the catheter for subsequent lung inflation.
Device Story
Manual jet ventilator system; provides oxygen delivery for transtracheal ventilation. Input: oxygen source. Operation: manual, intermittent jetting of oxygen through a transtracheal catheter or cricothyrotomy needle inserted into the cricothyroid membrane. Output: lung inflation. Used in emergency clinical settings for airway management. Operated by clinicians. Benefits: provides emergency ventilation in cases of upper airway obstruction.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Manual oxygen delivery system; mechanical operation; no electronic components or software; designed for use with transtracheal catheters or cricothyrotomy needles.
Indications for Use
Indicated for patients experiencing emergency upper airway obstructions requiring transtracheal ventilation via cricothyroid membrane access.
Regulatory Classification
Identification
A powered emergency ventilator is a demand valve or inhalator intended to provide emergency respiratory support by means of a face mask or a tube inserted into a patient's airway.
Related Devices
- K112783 — MANUJET III · VBM Medizintechnik GmbH · Dec 22, 2011
- K082600 — OXYLOG 2000 PLUS SYSTEM (MODEL 5705080), OXYLOG 2000 PLUS BASIC DEVICE (MODEL 5705082) · Draeger Medical B.V. · Nov 26, 2008
- K012271 — ACUTEVENTILATOR · Impoex International, Ltd. · Oct 4, 2002
- K132759 — VENTRAIN · Dolphys Medical B.V. · Mar 26, 2014
- K181583 — Adult Single Use Resuscitator Bag without Pressure Relief, Adult Single Use Resuscitator Bag + Pressure Relief 40CMH20, Adult Single Use Resuscitator Bag + Pressure Relief 60CMH20, Pediatric Single Use Resuscitator Bag + Pressure Relief 40CMH20, Infant Single Use Resuscitator Bag + Pressure Relief 40CMH20 · Flexicare Medical Limited. · Dec 7, 2018
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle with its wings spread.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 1 7 1999
Ms. Tricia Wood Regulatory Affais/Quality Assurance Manager Instrumentation Industries, Inc. 2990 Industrial Boulevard Bethel Park, PA 15102
Re: K991785 Manual Jet Ventilator Requlatory Class: II (two) Product Code: 73 BTL Dated: May 20, 1999 Received: May 25, 1999
Dear Ms. Wood:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to leqally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such Failure to comply with the GMP regulation may result in assumptions. regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{1}------------------------------------------------
Page 2 - Ms. Tricia Wood
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Thomas J. Collehan
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radioloqical Health
Enclosure
{2}------------------------------------------------
## INDICATION FOR USE STATEMENT
BE 183-SUR and BE 183-SU Manual Jet Ventilators Device:
Manually-controlled oxygen delivery system used for transtracheal ventilation. Summary:
The BE 183-SUR and BE 183-SU Manual Jet Ventilators are designed to provide transtracheal ventilation in specific emergency situations of upper airway obstructions. These systems are used in conjunction with a transtracheal catheter, or cricothyrotomy needle, which is inserted through the cricothyroid membrane. Ventilation is accomplished by the manual, intermittent jetting of oxygen through the catheter for subsequent lung inflation.
Tμci W
Signature
Signature
Tricia Wood Typed Name
5/21/99
---
Date
991785
Premarket notification (510(k)) number
Mr. Pruf
(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices
510(k) Number
